Cross-Sector entity

Paolo De Coppi

Person
8

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Great Ormond Street Hospital, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention Paolo De Coppi, all published on March 20, 2026.

1 verified story tracked

Last mentioned: Mar 20, 2026

Entity pulse

Recent coverage · Paolo De Coppi

1 story
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Paolo De Coppi

Every one of those 1 sits in a single category, medical-devices. Of the tracked stories, 1 of 1 also mention Great Ormond Street Hospital, the most common co-covered peer. Each carries 3 original sources on average. We currently track 1 Cross-Sector story that mention Paolo De Coppi, all published on March 20, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Paolo De Coppi. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Commercial Scalability Assessment

    Evaluation of bio-foundry partnerships to standardize the production of engineered scaffolds.

  2. Regulatory Submission

    Expected filing for Advanced Therapy Medicinal Product (ATMP) designation with the MHRA.

  3. Expanded Clinical Trials

    Anticipated start of Phase II trials involving a larger cohort of pediatric patients with long-gap OA.

  4. Breakthrough Announcement

    First successful lab-grown oesophagus for pediatric use is unveiled to the public.

Stories mentioning Paolo De Coppi 1

Healthcare medical devices Strongly positive 8

First Lab-Grown Oesophagus Offers Hope for Children with Rare Conditions

Researchers have successfully engineered the first lab-grown oesophagus, providing a transformative solution for children born with Oesophageal Atresia. This tissue-engineered breakthrough uses a patient's own cells to create a functional organ, potentially eliminating the need for high-risk invasive surgeries.

3 sources

Source: oxfordmail.co.uk · london-now.co.uk